TERF2 and sickle cell disease: On the contrary, an in vitro study showed that hydroxyurea (HU), an important drug therapy for sickle cell anemia that prolongs survival, affects telomere replication and reduces the telomere DNA synthesis rate through a mechanism that may involve TRF2 direct modification.23